Today we feature some promising news for people dealing with gluten issues from celiac disease. We also report on studies that appear to debunk cannabis as a sleep enhancer, and another way in which artificial intelligence could help people monitor and ​better understand various health conditions.

It's Nobel Prize season and today we feature promising early results of a novel technique for treating blindness that made Nobel laureates of three scientists this week. We also report on ​two studies comparing treatment options presented at the American Society for Radiation Oncology meeting.

With all the dire predictions about AI's potential to wipe out humanity, today we highlight two studies that use the technology for potential medical advances. We also report on a discovery at the ​cellular level that explains how tobacco smoke exposure can lead to lung cancer.

Today we highlight a potentially unexpected benefit of appendectomy and some underreported side effects of wildly popular GLP-1 drugs used for weight loss and diabetes. We also cover promising results of an experimental therapy being ​tested for the crippling muscle disorder that hit singer Celine Dion.

Today we report on a real-world study that may help inform which ​drug is the best GLP-1 option for those with significant recent weight gain. We also cover a study in mice that sheds light ‌on unanswered questions about allergic reactions in people.

人工知能（ＡＩ）開発企業アンソロピックと医療情報プラットフォー​ムのオープンエビデンスは２２日、ＡＩを活用し‌た臨床意思決定支援ツールを中低所得国の医師に提供するため提携すると発表した。

Artificial intelligence startup Anthropic and medical knowledge platform OpenEvidence are collaborating to bring AI-powered clinical decision support to physicians in regions without access to the technology, the companies ​said on Tuesday.

Today we feature an important ​genetic discovery that could help identify never-smokers at high risk of developing lung cancer. We also report on a study that ‌aimed to make a common gynecological procedure less painful.

Hello Health Rounds readers! Today we ​highlight a potentially game-changing experimental contrast agent for MRI exams that may enable detection of lung cancer when tumors are ‌small and more treatment options are available. We also report on a Johnson & Johnson antidepressant that appears to help improve sexual dysfunction in patients with major depressive disorder.

An experimental ​peptide backed by U.S. Health Secretary Robert F. Kennedy Jr. and marketed online for pain, healing and performance enhancement is being ‌used for a wide range of ailments despite little safety and efficacy evidence from human studies, a new analysis found.

For those who find night driving increasingly difficult, today we have some encouraging news that might make those oncoming headlights ​less problematic. We also report on a survey from U.S. cancer centers that reveals the need for incentives to boost manufacturing of critically important but less ‌profitable generic oncology treatments.

Major questions remain about whether exposure to the toxins and the trauma on 9/11 and afterward increased children's ​long-term health risks, according to scientists.

Today we feature data from studies being presented at the ongoing European Respiratory Society Congress in Barcelona.

Today we feature two early studies, one that points toward a possible way to prevent nerve damage ​from chemotherapy drugs and another that reveals previously unrecognized effects of bacteria that are known to make adults very sick but that ‌were thought to be harmless to babies.

We also report on a study that may have found a way to prevent liver damage caused by fatty liver diseases, which ​affect millions of people.

People taking popular GLP-1 obesity drugs who remain on low starter doses will ​lose some weight but may still experience side effects, although significantly less nausea than those who graduate ‌to higher manufacturer-recommended doses, a new study suggests.

We also share data confirming that U.S. airline flight crews are at high risk ​of cancer from cosmic radiation.

We also report on a flavoring chemical in e-cigarettes that damages human embryo cells in lab experiments.

We also share a report from cardiologists that suggests you might (or might not) want to check your waist and hip measurements, and a laboratory study with some encouraging news about brain tumor treatments.

We also feature a small study that should reassure women about the safety ​of becoming pregnant after undergoing CAR T-cell therapy for autoimmune diseases.